Suraksha Diagnostic Ltd IPO

Our Company was incorporated as `Suraksha Diagnostic Private Limited' as a private limited company under the Companies Act, 1956 pursuant to a certificate of incorporation dated March 15, 2005, issued by the Deputy Registrar of Companies, West Bengal at Kolkata. Subsequently, our Company was converted into a public limited company pursuant to a special resolution passed in the extra-ordinary general meeting of our Shareholders held on June 5, 2024, and consequently, the name of our Company was changed to `Suraksha Diagnostic Limited', and a fresh certificate of incorporation dated July 16, 2024, was issued by the Registrar of Companies, Central Processing Centre.

The Indian diagnostics services market, estimated to at Rs.860 to Rs.870 billion in Fiscal 2024, is projected to grow at CAGR of around 10%-12% to Rs.1,275-Rs.1,375 billion by Fiscal 2028, out of which the eastern and north-eastern India market, estimated at Rs.170-Rs.180 billion in Fiscal 2024, is projected to grow at CAGR of around 10.50%-12.50% to Rs.260-Rs.280 billion by Fiscal 2028. (Source: CRISIL Report, as replicated on page 196). Particularly, the West Bengal market, estimated at Rs.61 to Rs.63 billion in Fiscal 2024, is projected to grow at CAGR of around 10.50%-12.50% to Rs.95 to Rs.100 billion by Fiscal 2028.

We offer one stop integrated solutions for pathology and radiology testing and medical consultation services including X-rays, ultrasonography, computerized tomography, magnetic resonance imaging scans and vaccination services through our operational network, consisting of our flagship central reference laboratory, 8 satellite laboratories (co-located with our diagnostic centers) and 215 customer touchpoints which include 49 diagnostic centres, and 166 sample collection centres (primarily franchised), as of June 30, 2024 across the states of West Bengal, Bihar, Assam, and Meghalaya. We generate revenue primarily through sales of our diagnostic services as mentioned above.